Literature DB >> 33822432

Insertion of an SVA element in MSH2 as a novel cause of Lynch syndrome.

Ciyu Yang1, Yirong Li1, Magan Trottier2, Michael P Farrell3, Vikas K Rai1, Erin E Salo-Mullen2, David J Gallagher3, Zsofia K Stadler2, Heleen M van der Klift4, Liying Zhang1,5.   

Abstract

Germline mutations in the DNA mismatch repair (MMR) genes cause Lynch syndrome (LS). In this study, we identified and characterized a novel SINE-VNTR-Alu (SVA) insertion in exon 12 of MSH2 in an individual with early-onset colorectal cancer and a very strong LS family history. RT-PCR analysis indicated a larger aberrant MSH2 transcript in one of the family members. MSK-IMPACT next-generation sequencing and long-range PCR analyses revealed an insertion in MSH2 exon 12 at the c.1972 position in an antisense orientation. The insertion was further characterized as an SVA element approximately 3 kb in length, belonging to the SVA_F1 family of retrotransposons. This variant also segregated with LS related cancers in four affected family members in this family. Based on this evidence, this MSH2 SVA insertion is considered pathogenic.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  Lynch syndrome; MSH2; SVA; germline

Mesh:

Substances:

Year:  2021        PMID: 33822432     DOI: 10.1002/gcc.22950

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   4.263


  3 in total

1.  Retrotransposon insertion as a novel mutational cause of spinal muscular atrophy.

Authors:  Myriam Vezain; Christel Thauvin-Robinet; Yoann Vial; Sophie Coutant; Séverine Drunat; Jon Andoni Urtizberea; Anne Rolland; Agnès Jacquin-Piques; Séverine Fehrenbach; Gaël Nicolas; François Lecoquierre; Pascale Saugier-Veber
Journal:  Hum Genet       Date:  2022-09-23       Impact factor: 5.881

Review 2.  Mechanisms of disease-associated SINE-VNTR-Alus.

Authors:  Abigail L Pfaff; Lewis M Singleton; Sulev Kõks
Journal:  Exp Biol Med (Maywood)       Date:  2022-04-06

Review 3.  Lynch Syndrome and MSI-H Cancers: From Mechanisms to "Off-The-Shelf" Cancer Vaccines.

Authors:  Vladimir Roudko; Cansu Cimen Bozkus; Benjamin Greenbaum; Aimee Lucas; Robert Samstein; Nina Bhardwaj
Journal:  Front Immunol       Date:  2021-09-24       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.